Our Company Strategy & Mission Leadership Our Board Partnering Opportunities Out-Licensing Opportunities Contact Our Pipeline Clinical Trials Disease Information Innovation Engine Akeso Partnership Overview Ivonescimab (SMT112) Overview Therapeutic Areas News Center Media Resources Press Releases Investor Center Investor Center Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Board of Directors Diversity Matrix Shareholder Meetings Summit Presentations Career Opportunities
Resistance Development Studies With Ridinilazole (RDZ) and Clostridium difficile Resistance Development Studies With Ridinilazole (RDZ) and Clostridium difficile June 20, 2016 By CKD Digital
Resistance Development Studies With Ridinilazole (RDZ) and Clostridium difficile June 20, 2016 By CKD Digital
Website Cookies This website uses cookies: Please see our Privacy Policy to understand how we use cookies. Okay, thanks
